Evaluation of the Contribution of Lower Limb and/or Abdominal Compression on Orthostatic Hypotension
HYPOFLEX
1 other identifier
interventional
44
1 country
2
Brief Summary
Orthostatic hypotension (OH) is associated with an increased risk of myocardial infarction, stroke, heart failure and neurocognitive disorders. In the elderly, OH is an independent predictor of falls and mortality. Non-drug treatments are used as the first-line treatments. Among non-drug treatments, compression of the lower limbs and abdominal compression have been shown to help reduce OH and associated symptoms. As these studies were solely based on ankle-to-thigh bandages, the effectiveness of other medical devices developed, such as compression socks and tights, needs to be evaluated. In addition, data comparing the efficacy and tolerability of several approaches, single or combined, of several levels of compression, provided by socks, tights and an abdominal belt are scarce. The HYPOFLEX study aims to provide new data to enable better management of OH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2024
CompletedFirst Posted
Study publicly available on registry
November 19, 2024
CompletedStudy Start
First participant enrolled
February 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 16, 2025
September 1, 2025
7 months
November 8, 2024
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare the blood pressure reduction induced by supine/standing postural change in the absence and presence of lower limb compression.
Decrease in systolic BP when moving from the supine to the standing position, using a semi-automatic blood pressure monitor (Dynamap type): * supine BP: average of 3 measurements taken after a rest of at least 5 minutes * BP in upright position: lowest value of measurements obtained every minute for 5 minutes after rising, Without compression and with class 2 compression of the lower limbs.
12 months
Secondary Outcomes (4)
Decrease in systolic blood pressure when moving from the supine to the upright position
12 months
Severity of orthostatic hypotension
12 months
Characterize orthostatic hypotension
12 months
Evaluate patient satisfaction and tolerance
12 months
Study Arms (1)
a single group of patients
OTHERSubject will undergo the following 5 conditions in the cross-over scheme as determined by the randomization: No compression, Class 2 compression socks, Class 3 compression socks, Class 2 compression tights and Dynabelt abdominal belt + Class 2 compression socks .
Interventions
The prevalence of orthostatic hypotension will be characterized by the percentage of patients with a decrease of ≥ 20mmHg in systolic blood pressure or ≥ 10mmHg in diastolic blood pressure following the supine/standing postural change position.
Eligibility Criteria
You may qualify if:
- Patient aged 60 or over,
- Patients hospitalized at Broca Hospital with orthostatic hypotension,
- Patient able to stand,
- Patient who has been medically stable for at least 48 hours,
- Patient whose measurements are compatible with Thuasne compression device sizes,
- Patient having been informed, having received answers to his questions and having signed the informed consent form prior to his participation in the study,
- Patient affiliated or entitled to a social security number.
You may not qualify if:
- Patients presenting, according to the investigator, a contraindication to lower limb and/or abdominal compression,
- Patients presenting any contraindication mentioned in the instructions for use of the medical devices under investigation.
- Patient presenting, according to the investigator, a major cognitive impairment incompatible with participation in a clinical trial,
- Patient taking part in another clinical investigation conducted to establish the conformity of a medical device having an impact on the outcomes,
- Vulnerable patient according to article L1121-6 of the Public Health Code, subject to a judicial protection measure or incapable of consenting to a clinical trial or incapable of giving informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Broca Hospital
Paris, 75013, France
Broca Hospital
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2024
First Posted
November 19, 2024
Study Start
February 14, 2025
Primary Completion
September 1, 2025
Study Completion
December 1, 2025
Last Updated
September 16, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share